PALO ALTO, Calif.--(BUSINESS WIRE)--Centrillion Technologies, a leading genomic technology company developing and commercializing transformative genomic analysis tools, announced today that Dr. Suzanne Dee has joined the company as Vice President, Product Science. Dr. Dee brings over twenty years of product development experience in biotechnology, genomics and diagnostics.
“We are thrilled to have Dr. Dee join us,” noted Dr. Wei Zhou, President and CEO of Centrillion Technologies. “Her contributions to successfully advancing genomics technology are significant. She's a great addition to the Centrillion team and will be a terrific asset as we achieve our mission.”
"Centrillion has assembled an excellent team with broad expertise in genomics, chemistry, engineering, and bioinformatics," added Dr. Dee. "I am very excited to join the company and have the opportunity to build a new generation of genomics technology."
Prior to joining Centrillion, Dr. Dee was Vice President, Array Development at Singular Bio, Inc. From 1996 to 2014, she was responsible for developing and commercializing microarrays and platforms for gene expression monitoring at Affymetrix. She began her career at Hybritech, one of the first biotechnology companies in San Diego. Dr. Dee earned her Ph.D. in Biological Chemistry from the University of California, Irvine and completed her postdoctoral research at the Brain Tumor Research Center at the University of California, San Francisco.
About Centrillion Technologies
Centrillion Technologies is enabling scientists to decode and analyze the full genome and helping them power breakthroughs across a multitude of previously unapproachable applications in human health, agriculture and environmental studies. Leveraging the latest advances in engineering and biochemistry, the company’s products and services can isolate, manipulate, visualize, and analyze intact kilobase and megabase fragments of DNA, all with an accurate, simple and affordable workflow. Founded in 2009, Centrillion is led by former Affymetrix executives, backed by leading venture capital and strategic investors and is headquartered in the center of innovation of Silicon Valley in Palo Alto, Calif. near Stanford University. For more information, please visit: www.CentrillionTech.com.